Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry

Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry

Bibliographic Details
Main Authors:	Ringold Sarah, Beukelman Timothy, Morgan DeWitt Esi M, Natter Marc, Nigrovic Peter A, Kimura Yukiko
Format:	Article
Language:	English
Published:	BMC 2012-07-01
Series:	Pediatric Rheumatology Online Journal
Online Access:	http://www.ped-rheum.com/content/10/S1/A46

Similar Items

2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis
by: Sarah Ringold, et al.
Published: (2014-09-01)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
by: Morgan DeWitt Esi M, et al.
Published: (2012-07-01)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
by: Mohammad Alkhreisat MD, et al.
Published: (2019-10-01)

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Beukelman, et al.
Published: (2021-08-01)

Clinical characteristics of children with juvenile dermatomyositis recruited within the first 7 months of the CARRAnet registry
by: Hoeltzel Mark F, et al.
Published: (2012-07-01)

Diagnostic evaluation and medication usage in a cohort of subjects with juvenile dermatomyositis from the CARRAnet registry
by: Robinson Angela B, et al.
Published: (2012-07-01)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
by: Zak M, et al.
Published: (2008-09-01)

Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis
by: Elissa R. Weitzman, et al.
Published: (2018-01-01)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
by: Alpigiani MG, et al.
Published: (2008-09-01)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
by: Carlomagno R, et al.
Published: (2011-09-01)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
by: Bracaglia C, et al.
Published: (2008-09-01)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008-09-01)

Parent and Patient Treatment Preferences in Juvenile Idiopathic Arthritis (JIA)
by: Montealegre Sanchez, Gina A.
Published: (2011)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
by: Verazza S, et al.
Published: (2008-09-01)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
by: Baildam EM, et al.
Published: (2008-09-01)

Replication of the association of the <it>COG6</it> gene with juvenile idiopathic arthritis (JIA)
by: Worthington J, et al.
Published: (2011-09-01)

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
by: Yukiko Kimura, et al.
Published: (2017-04-01)

Psoriasis and Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis (JIA) : A Longitudinal Study of the Nordic JIA Cohort
by: Ekelund, Maria
Published: (2020)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
by: Jelusic-Drazic Marija, et al.
Published: (2012-07-01)

How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
by: Nageswaran Savithri, et al.
Published: (2008-06-01)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008-09-01)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
by: Dehoorne J, et al.
Published: (2011-09-01)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
by: Stepanenko NY
Published: (2011-09-01)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
by: Hinze CH, et al.
Published: (2008-09-01)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
by: Horneff G, et al.
Published: (2008-09-01)

German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA)
by: Dueckers Gregor, et al.
Published: (2012-07-01)

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
by: Pope Chris, et al.
Published: (2011-09-01)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008-09-01)

Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)
by: Kumar Sharath, et al.
Published: (2012-11-01)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008-09-01)

Knee disease in juvenile idiopathic arthritis (JIA): correlation between clinical and ultrasonographic findings
by: McCarron M, et al.
Published: (2008-09-01)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008-09-01)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
by: Bullement A, et al.
Published: (2021-09-01)

Immune regulation in health and Juvenile Idiopathic Arthritis (JIA) : molecular mechanisms and regulatory T cells
by: Pesenacker, A. M.
Published: (2013)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017-06-01)

The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic
by: Cron Randy Q, et al.
Published: (2009-05-01)

Description of the localized scleroderma subgroup of CARRAnet
by: Wu Eveline, et al.
Published: (2012-07-01)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
by: Yamaguchi Ken-ichi, et al.
Published: (2012-07-01)

Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA).
by: Ebun Omoyinmi, et al.
Published: (2012-01-01)

Ultrasound guided joint fluid aspiration and corticosteroid injection in patients with juvenile idiopathic arthritis (JIA)
by: Heuck C, et al.
Published: (2008-09-01)